Concert Pharmaceuticals, Inc. (CNCE) financial statements (2021 and earlier)

Company profile

Business Address 65 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1301061532039614279
Cash and cash equivalents77531828419313
Short-term investments5559143176565066
Other undisclosed cash, cash equivalents, and short-term investments(2)(5)(8)000(0)
Receivables3010001
Contract with customer, asset  16
Deferred costs 0     
Other undisclosed current assets1010102221
Total current assets:1431171802069814482
Noncurrent Assets
Operating lease, right-of-use asset99
Property, plant and equipment6892222
Restricted cash and investments1112000
Other noncurrent assets00 0000
Other undisclosed noncurrent assets 222   
Total noncurrent assets:1721126333
TOTAL ASSETS:15913719321210014784
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5564343
Accounts payable0111111
Accrued liabilities1111111
Employee-related liabilities4333232
Taxes payable  00 0 
Deferred revenue 8
Debt 0    7
Deferred revenue and credits2116
Contract with customer, liability1
Other undisclosed current liabilities6411112
Total current liabilities:1017966719
Noncurrent Liabilities
Long-term debt and lease obligation1516     
Operating lease, liability1516
Liabilities, other than long-term debt3312991011
Deferred revenue and credits991011
Accounts payable and accrued liabilities0      
Deferred revenue33
Contract with customer, liability9
Deferred rent credit  3
Other undisclosed noncurrent liabilities  4    
Total noncurrent liabilities:181916991011
Total liabilities:28362515151630
Stockholders' equity
Stockholders' equity attributable to parent1311011681968613155
Common stock0000000
Additional paid in capital401296284273257252200
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(269)(195)(117)(76)(172)(121)(145)
Total stockholders' equity:1311011681968613155
TOTAL LIABILITIES AND EQUITY:15913719321210014784

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net1440577
Gross profit:81111440679
Operating expenses(81)(80)(66)(51)(51)(42)(39)
Operating income (loss):(73)(79)(56)93(51)25(31)
Nonoperating income (expense)13340(0)(1)
Investment income, nonoperating1331000
Other nonoperating income (expense) 003 (0)(1)
Interest and debt expense   (1) (0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(71)(76)(53)95(51)25(32)
Other undisclosed income from continuing operations before income taxes     0 
Income (loss) from continuing operations before income taxes:(71)(76)(53)95(51)25(32)
Income tax expense (benefit)0 (0)0 (0) 
Net income (loss):(71)(76)(53)96(51)24(32)
Other undisclosed net income (loss) attributable to parent(3)(2)(3)   0
Net income (loss) attributable to parent:(75)(78)(56)96(51)24(32)
Preferred stock dividends and other adjustments      (0)
Undistributed earnings (loss) allocated to participating securities, basic   (0)
Net income (loss) available to common stockholders, basic:(75)(78)(56)95(51)24(32)
Other undisclosed net income available to common stockholders, diluted   0   
Net income (loss) available to common stockholders, diluted:(75)(78)(56)95(51)24(32)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(71)(76)(53)96(51)24(32)
Other comprehensive income (loss)   95(51)24(32)
Comprehensive income (loss):(71)(76)(53)191(101)48(64)
Other undisclosed comprehensive loss, net of tax, attributable to parent(3)(2)(3)    
Comprehensive income (loss), net of tax, attributable to parent:(75)(78)(56)191(101)48(64)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: